Dixon Hubard Feinour & Brown’s Novartis NVS Stock Holding History

Dixon Hubard Feinour & Brown's NVS Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown increased its Novartis (NVS) stake by 11% in Q2 2022, buying an estimated $50.2K and bringing the position to 5,996 shares worth $507K. The position accounts for 0.06% of the portfolio, ranked #193.

Dixon Hubard Feinour & Brown first reported a position in NVS in Q1 2014 and has held it in 9 quarters since. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

• Dixon Hubard Feinour & Brown held 5,996 shares of Novartis worth $507K as of Q2 2022.
• Dixon Hubard Feinour & Brown bought 572 Novartis shares in Q2 2022, an estimated $50.2K.
• Novartis made up 0.06% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #193 holding.
• Dixon Hubard Feinour & Brown first reported a position in Novartis in Q1 2014 and has held it in 9 quarters since.
• 1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.